Homeperf

What Homeperf does

Homeperf (legal entity DOMCO) is a France-based home healthcare service provider (Prestataire de Santé à Domicile) founded in 1997 and headquartered in Aix-en-Provence. The company delivers complex home-based medical treatments through 38 regional agencies covering mainland France and Corsica, including home perfusion (antibiotic, pain, hydration, chemotherapy, immunotherapy), home parenteral and enteral nutrition (NPAD/NEAD), insulin pump therapy for Type 1 diabetes (with closed-loop system options), and apomorphine pump therapy for Parkinson's disease. The company is supported by a multidisciplinary workforce of 450-500 collaborators, including more than 115 coordinating nurses and 40 dietitians, several of whom hold specialized certifications (CESU Syndromes Parkinsoniens / DIU).

Its commercial model is B2B-to-patient: hospital physicians and specialists prescribe Homeperf services, field-based Délégués Hospitaliers develop prescriber relationships, and Homeperf teams deliver device installation, training, 24/7 support, and ongoing monitoring directly to patient homes. Revenue flows primarily through French health insurance reimbursement under regulated PSAD tariffs, with a smaller professional services stream from pharmaceutical partners (patient support programs, Phase IV clinical trial support, home drug delivery from hospital pharmacies). The proprietary Link4Life digital platform, created by two physicians, enables real-time patient monitoring, secure inter-professional messaging, alert management, and clinical study support across the care pathway.

Homeperf has been a subsidiary of Italian medical and industrial gases group Sapio Group since 2020, and is currently executing an aggressive consolidation strategy: between late 2025 and mid-2026, it divested its respiratory assistance branch to Synapse Santé (October 2025), acquired a new artificial nutrition business (November 2025), acquired Orkyn's enteral nutrition branch (January 2026), and was extended through Sapio's acquisition of EXPERF / New Medical Concept (May 2026), positioning it as a leading national provider of home perfusion and enteral nutrition services. Operational certifications include ISO 9001 (held since 1999), QUALIPSAD quality labeling, GDPR compliance, and a Gender Equality Index score of 89/100 (2025 and 2026).

Name

Homeperf

Legal name

DOMCO

Website

https://homeperf.com

Company type

Private

Founded year

1997

Operating status

Operating

Headcount range

251–500 employees

Short description

Homeperf is a France-based home healthcare provider (PSAD) operating 38 agencies nationwide, delivering home perfusion, parenteral and enteral nutrition, insulin pump therapy, and apomorphine pump treatment for Parkinson's patients, reimbursed through French health insurance and supported by its Link4Life digital platform.

Ownership category

akta.pro rank

Product category

Home Healthcare Services

NAICS

Home Health Care Services (6216), Services for the Elderly and Persons with Disabilities (62412)

SIC

Services-Home Health Care Services (8082), Services-Health Services (8000)

akta.pro primary industry

Home-Based Chronic Disease Management (Skilled) (HLADAFAL)

akta.pro secondary industries

Home Infusion Therapy & IV Nursing Services (HLADAFAG), Diabetes Education & Insulin Management (Home-Based) (HSABACAJ)

Keywords

• Home healthcare services
• Home infusion therapy
• Clinical nutrition services
• Insulin pump therapy
• Parkinson's home care

Headquarters

HQ city

Aix-en-provence

HQ country

France

HQ region

Europe

Offices38 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Home Healthcare Services - Perfusion: Provider of home perfusion services including antibiotic therapy, pain treatment, hydration, chemotherapy, and immunotherapy for chronic conditions such as diabetes and neurodegenerative diseases. Revenue derived from health insurance reimbursements and social security billing.
2. Home Healthcare Services - Nutritional Assistance: Home parenteral nutrition (NPAD) and home enteral nutrition (NEAD) services, coordinated by dietitians, with monitoring and follow-up. Billed through health insurance reimbursement systems.
3. Insulin Pump Therapy: Insulin pump provision, training, and ongoing support for Type 1 diabetic patients, coordinated with initiating diabetes centers. Reimbursed through French health insurance.
4. Apomorphine Pump for Parkinson's Disease: Specialized treatment for Parkinson's disease patients using apomorphine pumps, with dedicated expert nurses holding specific certifications (CESU Syndromes Parkinsoniens / DIU).
5. Drug Delivery and Clinical Support: Drug portage from hospital pharmacies to patient homes, clinical trial phase IV support, and patient support programs (PSP) in partnership with pharmaceutical companies.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

Homeperf is a French home healthcare provider delivering specialized clinical treatments at patients' homes, including home perfusion (antibiotic therapy, pain treatment, hydration, chemotherapy, immunotherapy), artificial nutrition (parenteral NPAD and enteral NEAD), insulin pump therapy for Type 1 diabetes, and apomorphine pump therapy for Parkinson's disease. Services are delivered through a nationwide network of 38 regional agencies staffed by coordinating nurses, dietitians, logistics agents, and field-based hospital representatives, and are supported by the proprietary Link4Life digital platform for real-time patient monitoring and care coordination.

Product overview

Homeperf is a home healthcare service provider offering a comprehensive portfolio of products and services organized around four core treatment areas: home perfusion, insulinotherapy by pump, Parkinson's disease treatment, and nutritional assistance. The company operates through a network of 38 agencies across France, providing coordinated care that connects hospital and home settings. Key digital offerings include Link4Life, a secure platform enabling real-time patient monitoring and care coordination between healthcare professionals. Additional services include wound care (via Synartis partnership), clinical trial support, patient support programs, drug delivery, psychological and social support, adapted physical activity programs, and home medical equipment coordination. Homeperf joined SAPIO Group in 2020, strengthening its position in home healthcare across Europe.

Differentiator

Problem solved

Functional benefit

Brands

• Link4Life: Digital solution for healthcare professionals to share patient information and coordinate care, enabling real-time monitoring from patients' homes.
• Home Prehab

Products and services

• Perfusion at Home Home-based perfusion services including antibiotherapy, pain treatment, hydration, and chemotherapy administration delivered by trained coordinating nurses for patients with acute or chronic conditions.
• Insulin Pump Therapy Type 1 diabetes treatment via insulin pumps (including patch pumps) with comprehensive training, ongoing support, and closed-loop system options (MiniMed 670G, DBLG1, Control-IQ).
• Parkinson's Disease Treatment (Apomorphine Pump) Continuous subcutaneous apomorphine delivery via pump for Parkinson's disease patients, including pre-visits, care coordination, training, and monthly follow-ups by specialized nurses.
• Nutritional Assistance (Parenteral and Enteral) Home parenteral nutrition (NPAD) and home enteral nutrition (NEAD) services coordinated by dietitians, including patient installation, follow-up, and protocol management.
• Urology and Transanal Irrigation Coordination of intermittent self-catheterization, collector systems, and transanal irrigation for patients with bladder or colorectal dysfunction.
• Link4Life Digital Platform Digital solution enabling healthcare professionals to share patient information, monitor patients in real-time from home, prevent complications, and coordinate care through secure messaging and alerts.
• Wound and Scar Healing Complex wound care services provided through Synartis (Sapio subsidiary), including training of liberal nurses and follow-up reports for complex surgical, Verneuil disease, or pilonidal cyst wounds.
• Clinical Trials Support Phase IV clinical trial support including protocol training, material management, medical delivery (including refrigerated 2–8°C), and data management.
• Patient Support Programs Therapeutic support programs for chronic disease patients, improving treatment understanding and adherence in collaboration with pharmaceutical laboratories.
• Drug Delivery Home medication delivery from hospital pharmacies (PUI) including temperature-controlled transport (ambient and refrigerated 2–8°C), periodic deliveries, and pharmacovigilance reporting.
• Psychological and Social Support Follow-up by psychologists and social workers providing listening support and administrative help for home care procedures, insurance, and care arrangements.
• Home Medical Equipment Medical equipment at home including hospital beds, pressure ulcer prevention, wheelchairs, walking aids, transfer assistance, and bathroom equipment coordinated through partner partnerships.
• Adapted Physical Activity (APA) Prescribed physical activity programs for chronic disease patients, particularly for Parkinson's patients and malnutrition-risk patients (cancer, major surgery), provided through trained APA coaches.

Quantifiable outcome

• 89/100 gender equality index score demonstrates commitment to workplace diversity and inclusion

Named customers5 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

Five partnerships are on record, tiered core and minor.

• Synartis (Subsidiary of Sapio Group)coreStrategic or Co-development PartnerSynartis is a specialized wound care company (17+ years of expertise) and subsidiary of Sapio Group. Homeperf works with Synartis to provide specialized care for complex wounds, delivering expert nursing services, training for liberal nurses, wound monitoring, and care protocol management for patients with complex surgical, Verneuil disease, or pilonidal cyst wounds.
• Link4LifecoreTechnology or IntegrationLink4Life is a proprietary digital solution developed by two physicians for care coordination. Homeperf offers this platform enabling real-time patient monitoring from home, secure messaging between healthcare professionals, alert systems, and clinical study support.
• EndomindminorGTM or Marketing PartnerHomeperf supports Endomind, an endometriosis patient association, as part of awareness campaigns (#MarsJaune) for endometriosis, a chronic inflammatory disease affecting 1 in 10 women in France.
• EXPERF (New Medical Concept)coreStrategic or Co-development PartnerSapio Group announced acquisition of New Medical Concept (parent company of EXPERF), a home health provider specializing in perfusion and nutrition services, from the French Bastide group. This strengthens Sapio's/ Homeperf's position as a leading provider of perfusion and artificial nutrition services in France.
• Medical equipment suppliersminorChannel Partner/ Reseller/ DistributorHomeperf partners with a major provider of home medical equipment for home maintenance services including hospital beds, pressure ulcer prevention/treatment, wheelchairs, walking aids, transfer assistance, and bathroom equipment.

Scale indicators7 records

Recent moves9 records

Expansion highlights6 records

Direct peers

• Orkyn': French home healthcare provider (Air Liquide subsidiary) specializing in perfusion, nutrition, insulin therapy, and respiratory care. Direct competitor in identical therapy verticals across France; Homeperf recently acquired Orkyn's enteral nutrition branch.
• Elivie: Major French PSAD providing home perfusion, nutrition, insulin pump, and respiratory services with a national network. Closest direct competitor by service mix and geographic coverage.
• Bastide Group: French-listed home healthcare and medical equipment provider offering perfusion, nutrition, and respiratory services at home. Previous parent of EXPERF (now Sapio) and direct PSAD competitor.
• VitalAire (Air Liquide Healthcare): Air Liquide's home respiratory and chronic disease division operating across France. Comparable home-care delivery model with overlapping therapy areas (respiratory, perfusion, sleep apnea).
• EXPERF (New Medical Concept): French home perfusion and nutrition services provider; now part of Sapio Group alongside Homeperf following 2026 acquisition. Same therapy verticals and PSAD service model.
• Baywater Healthcare: UK home healthcare provider (Sapio Group subsidiary since 2025) specializing in home oxygen, ventilation, and respiratory therapies. Sister company within Sapio Group with comparable care delivery model.

Emerging players

• Synapse Santé: French home respiratory assistance provider that acquired Homeperf's respiratory branch (Oct 2025). Specialty focus on respiratory home care; partial overlap with former Homeperf offering.

Broad incumbents

• Fresenius Kabi (Home Care): Global clinical nutrition and infusion therapy company with home parenteral nutrition services across Europe. Comparable in home infusion/nutrition vertical but operates as a large global medtech incumbent.
• Linde Healthcare (Home Care): Global medical gases and home respiratory care division of Linde. Overlaps with Homeperf's therapy areas via respiratory, infusion, and chronic disease management services internationally.

Regional players

• Santélys: Non-profit home healthcare association primarily serving northern France (Hauts-de-France). Comparable home perfusion, nutrition, and chronic disease management services but regionally focused.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/homeperf

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Homeperf